GLP-1 utilization is climbing and so are the costs. For payers and employers, the instinct is to restrict access, layer on prior authorizations and focus narrowly on pharmacy spend. The problem with that approach is it often backfires. Members discontinue…
On Demand
Presented by:
Presenters
Jennifer Jones, MSM, RD, CSOWM
Director of Clinical Solutions, Noom Health
